Phase 2 Brain Cancer Trial, Recruiting (NCT06051240)

Phase 2 Brain Cancer Trial, Recruiting NCT06051240 Sponsor: Region Stockholm Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06051240 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Be older than 5 years of age
Be younger than 18 years old at the time they received radiation therapy
Have received radiation treatment to the brain or spine for a brain tumor within the last 7 years
Be using an adequate form of birth control throughout the entire treatment period and for six months after, if applicable*
Have a negative pregnancy test at the start of the study and each month during it, if applicable*
Have given written consent (or have a parent/caregiver give consent) to take part in the study

Who may not be able to join:

Anyone with a known allergy or sensitivity to lithium or any of its ingredients
Anyone with significant kidney problems (based on a specific kidney function test result)
Anyone with heart failure or certain heart conditions, including a condition called Brugada syndrome, or a close family member with that condition
Anyone with an uncontrolled underactive thyroid
Anyone who is pregnant or breastfeeding
Anyone with a serious imbalance of fluids or salts in their body
Anyone whose general health and ability to carry out daily activities falls below a certain level (confirm with trial site)
Anyone whose estimated chance of surviving 2 years is less than 25%, who is unlikely to follow the study schedule, who cannot swallow tablets, or who has significant language difficulties
Anyone already taking part in another clinical trial that would prevent them from joining this one

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06051240

Sponsor: Region Stockholm

Phase: Phase 2

Status: Recruiting

Condition: Brain Cancer

More information: https://clinicaltrials.gov/study/NCT06051240

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Be older than 5 years of age
Be younger than 18 years old at the time they received radiation therapy
Have received radiation treatment to the brain or spine for a brain tumor within the last 7 years
Be using an adequate form of birth control throughout the entire treatment period and for six months after, if applicable*
Have a negative pregnancy test at the start of the study and each month during it, if applicable*
Have given written consent (or have a parent/caregiver give consent) to take part in the study

Who may not be able to join:

Anyone with a known allergy or sensitivity to lithium or any of its ingredients
Anyone with significant kidney problems (based on a specific kidney function test result)
Anyone with heart failure or certain heart conditions, including a condition called Brugada syndrome, or a close family member with that condition
Anyone with an uncontrolled underactive thyroid
Anyone who is pregnant or breastfeeding
Anyone with a serious imbalance of fluids or salts in their body
Anyone whose general health and ability to carry out daily activities falls below a certain level (confirm with trial site)
Anyone whose estimated chance of surviving 2 years is less than 25%, who is unlikely to follow the study schedule, who cannot swallow tablets, or who has significant language difficulties
Anyone already taking part in another clinical trial that would prevent them from joining this one

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Region Stockholm

Registry

ClinicalTrials.gov

Start date

16 February 2024

Est. completion

31 August 2030

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Processing Speed Index (PSI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov